Neumarkt, Germany

Ricarda Wessel

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ricarda Wessel: Innovator in Topical Pharmaceutical Compositions

Introduction

Ricarda Wessel is a notable inventor based in Neumarkt, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of topical compositions for skin disorders. Her innovative work has the potential to improve the quality of life for many patients suffering from various skin conditions.

Latest Patents

Ricarda Wessel holds a patent for her invention titled "Topical pharmaceutical compositions." This patent describes compositions that include: a) 0.01 to 0.2 wt. % of mometasone furoate, b) 5 to 18 wt. % of hexylene glycol, c) 20 to 40 wt. % of water, and d) 25 to 70 wt. % of an oil phase. These compositions are designed to be stable and can be safely applied over large surface areas of the skin. They are particularly effective for the treatment or prevention of psoriasis, atopic dermatitis, and other skin disorders.

Career Highlights

Ricarda Wessel is associated with Almirall, S.A., a company known for its focus on dermatology and innovative treatments. Her work at Almirall has allowed her to contribute to the advancement of pharmaceutical solutions that address pressing health issues.

Collaborations

Throughout her career, Ricarda has collaborated with esteemed colleagues such as Fritjof Evers and Henning Mallwitz. These collaborations have fostered an environment of innovation and have led to the successful development of her patented compositions.

Conclusion

Ricarda Wessel's contributions to the field of topical pharmaceuticals highlight her dedication to improving patient care. Her innovative compositions represent a significant advancement in the treatment of skin disorders, showcasing her role as a leading inventor in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…